Liu Zheng,Chai Chengwei,Yang Jiliang,et al.Perioperative blood pressure management of pheochromocytoma in children: a report of 6 cases[J].Journal of Clinical Pediatric Surgery,,21():675-679.[doi:10.3760/cma.j.cn101785-202008064-015]
Perioperative blood pressure management of pheochromocytoma in children: a report of 6 cases
- Keywords:
- Pheochromocytoma; Perioperative; Blood Pressure; Child
- Abstract:
- Objective To explore the perioperative blood pressure management of pheochromocytoma to maintain relatively stable hemodynamics and prevent cardiovascular complications.Methods From January 2009 to December 2019, retrospective reviews of clinical data were conducted for 6 surgical children with pheochromocytoma.And the latest relevant domestic and foreign literatures were retrieved from PubMed.Results Preoperative blood pressures of 6 boys were controlled within a certain range according to the basis of blood pressure and physician advice.Hypertension was appropriately treated with blood pressure lowering drugs to gradually reduce their blood pressure to <130/80 mmHg and blood pressure <80/45 mmHg was avoided.After vigorous perioperative blood pressure managements, no such severe complications as malignant hypertension, adrenal crisis and myocardial infarction occurred during and after operation.Conclusion Perioperative blood pressure management of pheochromocytoma is essential and it can effectively prevent perioperative complications and safeguard patient safety.
References:
[1] Ramachandran R, Rewari V.Current perioperative management of pheochromocytomas[J].Indian J Urol, 2017, 33(1):19-25.DOI:10.4103/0970-1591.194781.
[2] Pappachan JM, Raskauskiene D, Sriraman R, et al.Diagnosis and management of pheochromocytoma:a practical guide to clinicians[J].Curr Hypertens Rep, 2014, 16(7):442.DOI:10.1007/s11906-014-0442-z.
[3] García MIDO, Palasí R, Gómez RC, et al.Surgical and pharmacological management of functioning pheochromocytoma and paraganglioma//Brisbane (AU), 2019.DOI:10.15586/paraganglioma.2019.ch4.
[4] Dueck A, Poenaru D, Kamal I.Hypertension following minor trauma:a rare presentation of pheochromocytoma[J].Pediatr Surg Int, 1999, 15(7):508-509.DOI:10.1007/s003830050651.
[5] Ciftci AO, Tanyel FC, Senocak ME, et al.Pheochromocytoma in children[J].J Pediatr Surg, 2001, 36(3):447-452.DOI:10.1053/jpsu.2001.21612.
[6] Kim HY, Lee HS, Jung SE, et al.Experience with surgical excision in childhood pheochromocytoma[J].J Korean Med Sci, 2004, 19(3):401-406.DOI:10.3346/jkms.2004.19.3.401.
[7] Azadeh N, Ramakrishna H, Bhatia NL, et al.Therapeutic goals in patients with pheochromocytoma:a guide to perioperative management[J].Ir J Med Sci, 2016, 185(1):43-49.DOI:10.1007/s11845-015-1383-5.
[8] Sanath Kumar SB, Date R, Woodhouse N, et al.Successful management of phaeochromocytoma using preoperative oral labetalol and intraoperative magnesium sulphate:report of four cases[J].Sultan Qaboos Univ Med J, 2014, 14(2):e236-240.
[9] Hull CJ.Phaeochromocytoma.Diagnosis, preoperative preparation and anaesthetic management[J].Br J Anaesth, 1986, 58(12):1453-1468.DOI:10.1093/bja/58.12.1453.
[10] Tian J, Bao Z, Yuan Y, et al.The Duration of preoperative administration of single α-receptor blocker phenoxybenzamine before adrenalectomy for pheochromocytoma:18 years of clinical experience from nationwide high-volume center[J].Biomed Res Int, 2019, 2019:2613137.DOI:10.1155/2019/2613137.
[11] Kwon SY, Lee KS, Lee JN, et al.Risk factors for hypertensive attack during pheochromocytoma resection[J].Investig Clin Urol, 2016, 57(3):184-190.DOI:10.4111/icu.2016.57.3.184.
[12] Lord MS, Augoustides JG.Perioperative management of pheochromocytoma:focus on magnesium, clevidipine and vasopressin[J].J Cardiothorac Vasc Anesth, 2012, 26(3):526-531.DOI:10.1053/j.jvca.2012.01.002.
[13] Pacak K, Linehan WM, Eisenhofer G, et al.Recent advances in genetics, diagnosis, localization and treatment of pheochromocytoma[J].Ann Intern Med, 2001, 134(4):315-329.DOI:10.7326/0003-4819-134-4-200102200-00016.
[14] Mamilla D, Araque KA, Brofferio A, et al.Postoperative Management in Patients with Pheochromocytoma and Paraganglioma[J].Cancers (Basel), 2019, 11(7):936.DOI:10.3390/cancers11070936.
[15] Atuk NO.Pheochromocytoma:diagnosis, localization, and treatment[J].Hosp Pract (Off Ed), 1983, 18(4):187-202.DOI:10.1080/21548331.1983.11702524.
[16] Pacak K.Preoperative management of the pheochromocytoma patient[J].J Clin Endocrinol Metab, 2007, 92(11):4069-4079.DOI:10.1210/jc.2007-1720.
Memo
收稿日期:2020-08-25。
通讯作者:邹焱,Email:monknut@126.com